Action potentials were recorded via intracellular microelectrodes, together with recordings of isometric-contractile tension, from isolated trabecular muscles of canine ventricle. The effects of administration of ouabain solution in concentrations varying from 1.7 X l(h 7 to 5 X 1CH M were recorded. The early inotropic effects of ouabain (increase in contractile force) were accompanied by changes in configuration of the action potential identical to those associated with interval-dependent potentiation in the control state, that is, abbreviation of phase 2 and lengthening of phase 3, without significant change in duration of the action potential. The progressive administration of ouabain, while associated with contractile enhancement of the regularly stimulated contraction was also accompanied by a loss of the contractile increment associated with poststimulation potentiation; this loss of interval-dependent potentiation corresponds to a loss of interval-dependent alteration of the action potential. Thus, both interval-dependent contractile potentiation and ouabain inotropy correlate consistently with phase 2 abbreviation of the accompanying action potentials.
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• The inotropic action of digitalis is wellrecognized, rendering the glycoside one of the most effective drugs used clinically. It has been demonstrated, clinically and experimentally, that digitalis administration evokes more rapid and forceful shortening of myocardial fibers in the failing heart and probably also in normal myocardium (1) . Nevertheless, the mechanism by which cardiac glycosides elicit enhanced contractility is poorly understood. A relation of digitalis to calcium influx has been suspected because Ca 2 + administration is known to enhance contractile tension (2, 3) . The demonstration of digitalis inotropy in the virtual absence of From the Department of Medicine, Indiana University School of Medicine, and the Krannert Institute of Cardiology, Marion County General Hospital, Indianapolis, Indiana.
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Accepted for publication August 22, 1967. Ca 2+ (4) has, however, made this association uncertain. Still other investigators (5) (6) (7) (8) have described a temporal relation between potassium efflux and the inotropic activity of the glycoside. Yet, as with Ca 2 + , conflicting data from other studies (9) have cast doubt upon the relation of digitalis-induced K + efflux to contractile augmentation. Confronted, therefore, with contradictory data and uncertain hypotheses, some investigators (9) (10) (11) have contended that the inotropic property of digitalis may be more closely related to the contractile process itself and need not be reflected by electrophysiologically discernible alterations in transmembrane ionic flux or excitation-contraction coupling. Apparently lending support to such a postulate is the general observation (5, 9) that the inotropic effects of digitalis precede any "significant" alteration in the myocardial action potential. Tending further to support the dissociation of digitalis inotropy from the electrophysiologic manifestations of the glycoside is the prevalent notion (12, 13) that other types of 516 EDMANDS, GREENSPAN, FISCH procedures that increase contractile force are also unaccompanied by alterations in the action potential. Contractile enhancement, such as that observed in postextrasystolic potentiation and poststimulation potentiation, is not associated with changes in duration or magnitude of the action potential. It has been suggested, as a result, that these inotropic events also may involve primary alterations in the contractile process, rather than changes in excitation-contraction coupling sufficient to be reflected in action potential alteration. We have, however, noted characteristic AP changes in the action potential associated with interval-dependent contractile potentiation and depression (14, 15) . These studies have demonstrated that a relative abbreviation of the cycle-length is terminated by both a weaker contraction and an action potential with phase 2 prolonged and phase 3 shortened without significant change in total duration of the action potential. In contrast, following a relative prolongation of the cycle length, there is consistently observed a potentiation of contractile force; phase 2 of the action potential is shortened and phase 3 is prolonged, again without change in total duration of the action potential. There appears to be, moreover, a quantitative relation between the alterations in contraction and in the action potential that may be more fundamental than the magnitude of cycle-length change. Rest potentiation (potentiation after a much greater relative pause in the cycle-length) is associated with far less potentiation than that following an interpolated beat; the extent of alteration in the action potential is also much less. These various interval-dependent alterations in contractility are not associated with changes in the time-to-peak force. The contractile changes are, therefore, considered to represent positive inotropic effects involving altered force-velocity relations (12, 16) .
Cognizant, therefore, of what appears to be an electrophysiologic correlate of inotropic enhancement, we felt that reassessment of the relation between the electrophysiologic and inotropic properties of digitalis might prove fruitful. Accordingly, studies were in-itiated to assess further the effects of "therapeutic" doses of ouabain upon action potential configuration and contractile vigor.
Methods
Trabecular muscles, 0.5 to 1.0 mm in diameter, were removed from dog heart ventricles (5 experiments in 5 dogs) and placed in a muscle bath containing oxygenated Tyrode solution at 37°C. Following external stimulation (with threshold stimuli) at a basic rate of 60/min, contractile tension was recorded via a Statham transducer (Electronics for Medicine). Action potentials were recorded simultaneously from intracellular microelectrodes by conventional microelectrophysiologic techniques (14) . Control records were then obtained of the basic contractile response and configuration of the action potential. Similar measurements were made following a late interpolated stimulus. At this time, infusions of 1.7 X 10~7 M ouabain (3 experiments) and 6.8 x 10~7 M ouabain (2 experiments) were begun at 4.3 ml/min and at a temperature of 37°C with constant overflow suction of 4.3 ml/ min. Recordings of contractile tension and the action potentials were obtained at 2-to 3-min intervals over a period of 80 to 120 min. The experiments were terminated following the demonstration of gross reduction in amplitude of the action potential and loss of excitability (assuming the latter to reflect some degree of tissue deterioration or digitalis toxicity or both).
Results
Examination of the records shows that interval-dependent contractile potentiation is still present following ouabain administration, but the contractile increment is less, relatively and absolutely, than that observed in the control preparation. In addition, the earliest inotropic effect of the glycoside is associated with a change in configuration of the action potential; phase 2 is shorter and phase 3 is longer, usually without change in the total duration or amplitude of the action potential. These changes in the action potential were not observed in the absence of an inotropic response. Such changes were observed in each of the experiments, of which the following illustrations are representative. Figure 1 (obtained from experiment no. 3) shows the resultant action potentials and contractile tension when the regular sequence is interrupted by an interpolated stimulus. Action A sequence of regular stimuli (60/min) had been produced just before A. The sequence was interrupted at the arrow by an interpolated stimulus. The second contraction (TbJ after the interpolated stimulus was potentiated and phase 2 of the accompanying action potential (AP) (b) was shortened. Alterations of APb and Tb with respect to the dominant AP and contraction (AP, a and Ta respectively) are further illustrated by superimposition at the right of the tracing. Figure IB shows an identical sequence of events 107 min after the initiation of administration of ouabain. While there is an apparent increase in the force of the regularly stimulated contractions (represented by Taj, interval-dependent potentiation (TbJ is less prominent than in the control state. In addition, the accompanying AP (b) displays less shortening of phase 2 than is observed in the corresponding AP of the control state. These interval-dependent alterations in the configuration and contraction of the AP in the digitalized preparation are also illustrated by superimposition at the right of the tracing. Tension, voltage, and time calibrations are marked on the upper trace. potentials and contractile tension are recorded from the control preparation in Figure 1A , while Figure IB displays the electrical and mechanical response of the tissue 107 min after the onset of ouabain infusion. Following the relatively prolonged cycle-length (marked 1 sec), contractile force was increased almost twofold in the control preparation (poststimulation potentiation). This potentiation is also associated with distinct alteration in the action potential and with phase 2 shortened and phase 3 prolonged. With a progressive increase in the inotropic effect of ouabain upon the regularly stimulated muscle, however, one observes a progressive decrease in the degree of poststLmulation potentiation. Ultimately, in Figure IB , when the basic contractile force is enhanced 250% (close to the maximal inotropic response produced by oua-
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bain under the conditions of this experiment), interval-dependent contractile augmentation is negligible. In addition, it may be observed that the degree of alteration in the action potential correlates well with the degree of poststimulation potentiation; change in the action potential is minimal when contractile enhancement is markedly reduced, as is illustrated by superimposition at the end of the tracing.
Comparison of the regularly occurring contractions, prior to and following ouabain administration, also shows a close correlation between the ouabain-induced inotropic response and altered configuration in the action potential (as shown in Fig. 2 ). Figure 2A shows the stimulus sequence in the control preparation (identical to 1A). The early contractile potentiation of ouabain is associated Effect of ouabain upon the contractile force and configuration of the action potential (AP) of the regularly stimulated events (2B), upon interval-dependent changes in contractile tensions (2k) and upon configuration of AP (2C). Figure 2k is similar to Figure 1A . Using Figure 2k for reference purposes, the effect of ouabain upon the regularly stimulated contraction (Taj and AP (a) is displayed in 2Ba (7 mm of ouabain infusion) and 2Bb (66 min of ouabain infusion). In each case, the post-ouabain contraction and AP is contrasted with the control contraction and AP by superimpostiion. The inotropic effect of digitalis correlates with phase 2 shortening of the accompanying AP; the more prominent inotropic effect after 66 min is associated with more marked abbreviation of phase 2. Figure 2C displays a superimposition of the regularly stimulated contraction (Taj and accompanying AP (aj, upon the "poststimulation" contraction (Tb,) and AP (b), during the control state and at 38 and 107 min after the onset of ouabain infusion. In this series, it is to be observed that interval-dependent potentiation of contractility becomes progressively less with ouabain infusion as does the interval-dependent change in configuration of the AP. After 107 min of ouabain infusion, the interval-dependent change, in both contractile force and duration of phase 2, is barely discernible.
with an action potential with phase 2 shortened, without change in total AP duration of the action potential, as disclosed by examination of Figure 2B (a); this latter illustration exhibits superimposition of regularly stimulated action potentials and the accompanying contractile responses, during the control state and during the early minutes of ouabain administration. Figure 2B(b) illustrates the regularly elicited action potential and resultant contractile response from the control state, contrasted with those recorded later in the course of ouabain administration. In this lat-ter circumstance, the contractile response is augmented threefold over the control and is associated with an action potential that exhibits even greater loss of phase 2, with some shortening of duration of the action potential.
No change in resting potential or amplitude of the action potential was observed, despite the altered configuration of the action potential, prior to 120 min after drug administration. It may be observed also, that timeto-peak force did not vary with the enhancement of contractile force, and resting length is unaltered throughout the study, suggesting Figure 3 shows a prototype of the canine ventricular action potential (the solid line), with each phase identified. Phase 0 (0) is formed by rapid depolarization of the cell following appropriate stimulation with some reversal of polarity. Phase 1 (1) is the brief "spike" formed by the rapid return of transmembrane polarity to or near the depolarized state. Phase 2 (2) is the earlier, slow repolarization, often forming an ill-defined plateau. Phase 3 is the later, more rapid repolarization which brings the membrane potential to its resting state. Measurement of the duration of the AP at 20% repolarization is shown by the broken horizontal line. This measurement has been chosen arbitrarily as an index of duration of phase 2. Also shown on the figure is a second action potential (AP), superimposed upon the first, exhibiting a shortened "phase 2 duration," and marked by the broken line. This AP superimposition reflects the characteristic that the inotropic response to ouabain reflects an increased velocity of shortening of the contractile element. Figure 2C discloses, much as in Figure 1 , the progressive effect of the glycoside upon poststLmulation potentiation and the accompanying action potentials. Each figure in the sequence represents a superimposition of the baseline action potential upon the action potential associated with the potentiated contraction, in addition to superimposition of the corresponding contractile forces. As noted above, interval-dependent potentiation becomes progressively less prominent, in association with lessening of interval-dependent AP alteration. One may observe, as well, the striking similarity between the alteration in the action potential associated with poststimulation potentiation in the control (Figure 2C , a) and the alteration in the action potential associated with early digitalis inotropy (Figure 2B,a) . Of particular pertinence, here, is the obvious similarity between the accompanying changes in contractile force. change in the AP described in the text. The longer phase 2 is measured as duration a; the shorter phase 2 as duration b. The total duration of the AP is identical for both. A progressive increase in contractile force was observed over a period of 53 min of ouabain (1.7x 10~7 M ) infusion. Concomitantly, duration of phase 2 (i.e., action potential duration measured at 20% repolarization) was progressively abbreviated. Time-to-peak force (tp) remained unchanged throughout the study. 1.2 X 10^* mg ouabain/ml = 1.7 X 10~7 M ouabain. As in experiment no. 1, a progressive enhancement of contractile force occurred over 52 min of ouabain infusion (1.7 X 10~7 M ) . As before, duration of phase 2 was abbreviated in association with the increased force of contraction, while time-to-peak force (tp) remained unchanged, suggesting that the increased force reflects an increase in the velocity of contractile element shortening. When ouabain had been infused for 4 min, no contractile change and no change in phase 2 duration had occurred. In this experiment (the source of the illustrations in this study), progressive increase in contractile force was observed in association with abbreviation of phase 2. At 107 min after the onset of ouabain infusion, nevertheless, further phase 2 abbreviation was associated with slight lessening of contractile force. Time-to-peak force (tp) was diminished here, however, and it is suggested that a decrease in duration of the active state may preclude manifestation of an inotropic enhancement. Tables 1 to 5 present, in a chronologic fashion, the sequential changes in contractile force, phase 2 duration (see Fig. 3 for measurement) and time-to-peak force (tp) produced by ouabain administration in the 5 experiments. In Tables 1 to 3, in which a lesser concentration of ouabain was employed, a pro-gressive increase in contractile force is observed together with a decrease in duration of phase 2 and an unchanging time-to-peak force. The only deviation from the pattern is found at the termination of the experiment in Table 4 , at which point a slight lessening of contractile force is observed in association x10-4 5x10-4 5 x l ( H 5 x 1 0 -* In this experiment, as in experiment no. 5, ouabain was administered at a greater concentration (6.8 X 10~7 M ). Again, contractile enhancement was consistently associated with abbreviation of phase 2 and without change in time-to-peak force (tp). And, also as previously, the absence of contractile change was similarly associated with no change in phase 2 duration (i.e., at 14 and 15 min after the onset of the infusion, as well as 22 and 25 min after the onset of infusion). 5 X 10^* mg ouabain/ml = 6.8 x 10~7 M ouabain. In this experiment, the initial 11 min of ouabain infusion did not produce an increase in the force of isometric contraction. Substantial shortening of time-to-peak force (tp) was observed, however, without change in contractile force. Thus, a positive inotropic effect took place over this interval of time, while abbreviation of phase 2 occurred concomitantly. Subsequently, contractile force was increased progressively with further phase 2 abbreviation, but without change in tp.
with further phase 2 shortening. It is to be noted, however, that time-to-peak force is abbreviated here for the first time in the experiment. The lack of further increase in force with a simultaneous decrease in phase 2 duration presumably reflects the decrease in duration of the active state which, in turn, precludes full expression of the inotropic enhancement.
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A more concentrated solution of ouabain (6.8 X 10-7 M ) was employed in the experiments reported in Tables 4 and 5 , and this resulted in a more rapid attainment of inotropic enhancement. Table 4 shows, as in the other experiments, a progressive increase in tension development without change in timeto-peak force together with a progressive reduction in duration of phase 2. In Table 5 , however, the initial 11 min of ouabain administration are associated with a decreasing phase 2 and a decreasing time-to-peak force with no significant change in contractile force. This probably reflects an inotropic enhancement (i.e., an increased velocity of shortening) that is offset by a decrease in duration of the active state, yielding no net change in contractile force. Subsequently, contractile force increases substantially with further phase 2 shortening, without change in timeto-peak force. This initial response may be analogous to the commonly observed "lack" of beneficial effects of the glycoside upon individuals with normal hearts (in which inotropic enhancement occurs but is not manifest grossly because of reflex adjustments). These 5 experiments disclose a consistent inotropic enhancement, in association with ouabain administration, that correlates with a progressive reduction in phase 2 duration.
Discussion
The data derived from this study suggest at least a temporal relation between change in action potential and digitalis inotropy. Abbreviation of phase 2, without change in duration of the action potential, is associated with the early inotropic effects of the glycoside. Furthermore, alteration of the action potential of identical type has been consistently associated with interval-dependent potentiation in control preparations (14, 15) . The association of digitalis inotropy with change in the action potential is quite compatible with the findings of prior investigators (5, 9) who, while denying an association between the early drug-induced contractile enhancement and change in the action potential, have actually demonstrated alterations in configuration of the action potential that are comparable to those described here. Such change in the action potential was not considered significant, however, because duration and amplitude of the action potential remained unchanged. Nevertheless, the consistent relation of phase 2 shortening, irrespective of duration of the action potential, with both intervaldependent and digitalis inotropy suggests that the relation of phase 2 abbreviation with digitalis-induced contractile enhancement is of significance. The more prominent contractile augmentation associated with further digitalis administration is appropriately accompanied by even greater phase 2 abbreviation, with some shortening of duration of the action potential.
Most prior studies (17, 18) have demonstrated, as we have, that administration of the glycoside is associated with abolition of interval-dependent contractile enhancement, although some question remains (19) as to whether this effect is a therapeutic or toxic manifestation of the drug. In any case, in this study and under the temporal circumstances of the cycle-length alteration, the contractile increment associated with poststimulation potentiation is gradually reduced, relatively and absolutely, with the administration of the drug. Furthermore, the change in configuration of the action potential accompanying the contractile change also becomes progressively less. Thus, there appears to be a consistent temporal relation between configuration of the action potential and the inotropic effects of digitalis; this relation obtains both with the enhancement of regularly stimulated contractions and with the loss of interval-dependent potentiation. In addition, it may be noted that the association of this alteration in the action potential with both interval-dependent potentiation (in the control) and digitalis inotropy is quite appropriate; both types of contractile enhancement are thought to reflect a similar mechanical property, one of increased velocity of shortening of the contractile elements.
One may also suggest that the digitalisinduced loss of poststimulation potentiation may reflect a limit of the contractile capacity of the myocardium (at least to the extent that contractility may be enhanced by this particular interval-dependent change). Encroachment upon this limit, by digitalis inotropy, may preclude further contractile enhancement by interval-dependent mechanisms. And the concomitant loss of intervaldependent change in the action potential with digitalis administration lends further substance to the apparent relation between alteration in the action potential and contractile change, as well as to the contention that there may be a limit to the contractile capacity of the myocardium.
The physiologic mechanism by which these changes in the action potential are mediated remains uncertain; yet, assuming the genesis of repolarization to be related to K + efflux (20) , one may speculate that the alteration in the action potential (associated with contractile augmentation) is consonant with increased K + efflux or membrane permeability to K + . Other investigations have presented data relating increased contractility with paired pulses (21) and digitalis administration (5) to net K + efflux; Langer and Brady (6) suggest, in fact, that K + efflux is associated with facilitation of the access of Ca 2 + ions to the contractile site. Abbreviation of phase 2, occurring with both interval-dependent potentiation and digitalis inotropy, and perhaps related to increased K + efflux, is therefore quite compatible with the observation that net K + efflux relates to increased contractility. It should be observed, moreover, that this postulated mechanism, to explain the inotropic effects of digitalis, is quite consistent with the well-established (22) capacity of the drug to inhibit active intracellular transport of K + and, thus, to effect depletion of intracellular K + . Accordingly, one may suggest that the configuration of the action potential (i.e., phase 2 duration), in the pharmacologic as well as temporal circumstances described in this study, may represent an electrophysiologic correlate of the contractile state of the myocardium.
